Ninoxan (Nitrous Oxide, Oxygen)

Nitrous oxide and oxygen, the active ingredient in Ninoxan, is a gas presented as a mixed‑gas formulation for inhalation use. It delivers a controlled concentration of nitrous oxide together with supplemental oxygen to maintain adequate oxygenation while providing rapid analgesic and anxiolytic effects during procedural sedation, especially in dental and minor surgical settings.

GNH USA supplies Ninoxan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ninoxan, a nitrous oxide‑oxygen gas mixture, is used for analgesia and sedation in specific clinical contexts.

- Dental procedures: provides rapid onset analgesia and anxiolysis during extractions, restorations and other oral interventions. - Minor surgical procedures: facilitates patient comfort and reduces pain perception during minor skin or soft‑tissue surgeries. - Diagnostic imaging or endoscopy: offers conscious sedation to improve patient tolerance of procedures requiring stillness.

Ninoxan may cause a range of adverse reactions, from mild to serious. Monitoring and appropriate equipment are essential during administration.

Common Side Effects: - Nausea or vomiting - Dizziness or light‑headedness - Headache - Dry mouth or throat irritation - Euphoria or mild hallucination - Transient increase in heart rate

Serious or Rare Side Effects: - Hypoxia due to inadequate oxygen delivery - Respiratory depression or apnea - Loss of consciousness - Severe hypotension or arrhythmia - Allergic reaction (rash, urticaria, anaphylaxis) - Persistent neurological symptoms (e.g., tingling, numbness).

Prior to using Ninoxan, clinicians should assess patient suitability and ensure safe delivery conditions.

- Contraindications: avoid in patients with severe chronic obstructive pulmonary disease, untreated pneumothorax, or known hypersensitivity to nitrous oxide. - Monitoring: continuously monitor oxygen saturation, respiratory rate and level of consciousness throughout administration. - Equipment: use a calibrated delivery system with proper scavenging to limit occupational exposure. - Duration: limit exposure to the shortest effective period to reduce cumulative toxicity. - Interactions: exercise caution when combined with other central nervous system depressants. - Store at ambient temperature: keep cylinders upright in a well‑ventilated area, protect from direct sunlight and extreme heat.

Ninoxan can interact with other agents that depress the central nervous system or affect oxygen transport.

Major Interactions (Avoid): - Opioids or strong analgesics: may cause profound respiratory depression. - Benzodiazepines or barbiturates: increase risk of excessive sedation and loss of airway reflexes. - High‑concentration oxygen therapy: can reduce nitrous oxide efficacy and alter gas dynamics.

Moderate Interactions (Monitor Closely): - Alcohol: additive sedative effects may require dose adjustment. - Inhalational anesthetics (e.g., sevoflurane): may potentiate cardiovascular depression. - Vitamin B12 deficiency: chronic nitrous oxide exposure can exacerbate neurologic deficits.